Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
BMC Nephrol ; 23(1): 194, 2022 05 23.
Artículo en Inglés | MEDLINE | ID: mdl-35606754

RESUMEN

BACKGROUND: Genus Desulfovibrio species is a sulphate-reducing anaerobic gram-negative rod that resides in the human oral cavity and intestinal tract. It was reported as the causative pathogen of bacteraemia and abdominal infections, but not renal cyst infection, and Desulfovibrio fairfieldensis has higher pathogenicity than other Desulfovibrio species. CASE PRESENTATION: A 63-year-old man was on haemodialysis for end-stage renal failure due to autosomal dominant polycystic kidney disease. On admission, he had a persistent high-grade fever, right lumbar back pain, and elevated C-reactive protein levels. His blood and urine cultures were negative. He received ciprofloxacin and meropenem; however, there was no clinical improvement. Contrast-enhanced computed tomography and plain magnetic resonance imaging revealed a haemorrhagic cyst at the upper pole of the right kidney. The lesion was drained. Although the drainage fluid culture was negative, D. fairfieldensis was detected in a renal cyst using a polymerase chain reaction. After the renal cyst drainage, he was treated with oral metronidazole and improved without any relapse. CONCLUSIONS: To the best of our knowledge, this is the first reported case of a renal cyst infection with Desulfovibrio species. D. fairfieldensis is difficult to detect, and polymerase chain reaction tests can detect this bacterium and ensure better management for a successful recovery.


Asunto(s)
Bacteriemia , Quistes , Desulfovibrio , Riñón Poliquístico Autosómico Dominante , Bacteriemia/microbiología , Humanos , Masculino , Persona de Mediana Edad , Recurrencia Local de Neoplasia , Riñón Poliquístico Autosómico Dominante/complicaciones , Riñón Poliquístico Autosómico Dominante/diagnóstico por imagen
2.
Gan To Kagaku Ryoho ; 38(10): 1633-7, 2011 Oct.
Artículo en Japonés | MEDLINE | ID: mdl-21996958

RESUMEN

PURPOSES: This study was designed to clarify risk factors for the recurrence of stage II colon cancer in patients and to determine possible treatment options for postoperative adjuvant chemotherapy. SUBJECTS AND METHODS: The subjects were 132 patients with stage II colon cancer who underwent surgery in this department from January 1998 to December 2007. Various high risk factors for recurrence and factors indicative of poor prognosis were examined (age, gender, site of tumor, maximum tumor diameter, invasion depth, histopathological classification, D number, ly, v, number of biopsied lymph nodes, preoperative tumor marker values and presence of postoperative adjuvant therapy). RESULTS: The group with postoperative adjuvant therapy had a better prognosis than the others (p=0. 0168). Groups with an absence of postoperative adjuvant therapy (p=0. 041), presence of vessel involvement (p=0. 0127), and poorly-differentiated types (p=0. 027)were extracted in a multivariate analysis of risk factors for recurrence. CONCLUSIONS: Postoperative adjuvant therapy was effective for stage II colon cancer. Vessel involvement and poorly-differentiated types were risk factors for recurrence of stage II colon cancer.


Asunto(s)
Neoplasias del Colon/patología , Adulto , Anciano , Anciano de 80 o más Años , Antineoplásicos/uso terapéutico , Neoplasias del Colon/irrigación sanguínea , Neoplasias del Colon/tratamiento farmacológico , Terapia Combinada , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estadificación de Neoplasias , Recurrencia , Estudios Retrospectivos , Factores de Riesgo
3.
Gan To Kagaku Ryoho ; 37(6): 1113-6, 2010 Jun.
Artículo en Japonés | MEDLINE | ID: mdl-20567118

RESUMEN

A 64-year-old man was admitted to our hospital for severe anemia, and a thorough examination revealed an AFP-producing gastric cancer with multiple liver metastases. He was treated with S-1, and liver metastases were reduced. However, the originalgastric tumor did not disappeare. We administered paclitaxelas second-line treatment, and CDDP/CPT-11 as thirdline treatment, intravenously. In August 2006, liver metastases were not detected, so he underwent total gastrectomy and lymph node dissection. The final stage was StageIB(mp, n0). He has had no recurrence as of 36 months postoperatively.


Asunto(s)
Gastrectomía , Neoplasias Hepáticas/tratamiento farmacológico , Neoplasias Gástricas/tratamiento farmacológico , Neoplasias Gástricas/cirugía , alfa-Fetoproteínas/biosíntesis , Terapia Combinada , Humanos , Neoplasias Hepáticas/secundario , Masculino , Persona de Mediana Edad , Neoplasias Gástricas/metabolismo , Neoplasias Gástricas/patología
4.
World J Surg ; 33(9): 1815-21, 2009 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-19629583

RESUMEN

BACKGROUND: Past trials have shown perioperative immunonutrition to improve the outcome for patients with gastric cancer. The present study was designed to evaluate the effect of preoperative oral immunonutrition on cellular immunity, the duration of the systemic inflammatory response syndrome (SIRS), and detailed postoperative complications in patients with gastric cancer. METHODS: Sixty patients with gastric cancer were randomly assigned to two groups: one group received immune-enhanced formulas supplemented with arginine and omega-3 fatty acids (immune-enhancing diet (ID) group, n = 30); the other received standard formulas (conventional diet (CD) group, n = 30) for 7 days before the operation. These groups were well matched in terms of age, sex, operations, cancer stages, and intraoperative variables. The postoperative outcome was evaluated based on clinical variables, including postoperative infectious complications, noninfectious complications, and SIRS duration. In addition, the perioperative state of cellular immunity was evaluated and compared between the two groups. RESULTS: The incidence of postoperative infectious complications in the ID group (6%) was significantly (p < 0.05) lower than that of the CD group (28%). The duration of SIRS in the ID group (0.77 +/- 0.9 days) was significantly (p < 0.05) shorter than that in the CD group (1.34 +/- 1.45 days). The postoperative lymphocyte and CD4(+)T-cell counts significantly decreased (p < 0.05) in both groups. However, the number of CD4(+)T-cells on preoperative day 1 and postoperative day 7 was significantly (p < 0.05) higher in the ID group than in the CD group. CONCLUSIONS: Preoperative oral immune-enhanced formulas supplemented with arginine and omega-3 fatty acids enhanced the immune status of the patients, reduced the duration of SIRS, and decreased the incidence of postoperative infectious complications. CD4(+)T-cell immunity likely played an important role in the modulation of the postoperative immune and inflammatory response after gastrectomy.


Asunto(s)
Arginina/inmunología , Ácidos Grasos Omega-3/inmunología , Gastrectomía , Inmunidad Celular/efectos de los fármacos , Infecciones/inmunología , Complicaciones Posoperatorias/inmunología , Complicaciones Posoperatorias/prevención & control , Cuidados Preoperatorios , Neoplasias Gástricas/cirugía , Síndrome de Respuesta Inflamatoria Sistémica/inmunología , Síndrome de Respuesta Inflamatoria Sistémica/prevención & control , Administración Oral , Adulto , Anciano , Anciano de 80 o más Años , Análisis de Varianza , Arginina/administración & dosificación , Distribución de Chi-Cuadrado , Suplementos Dietéticos , Ácidos Grasos Omega-3/administración & dosificación , Femenino , Humanos , Incidencia , Infecciones/epidemiología , Recuento de Linfocitos , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias/epidemiología , Estadísticas no Paramétricas , Neoplasias Gástricas/inmunología , Síndrome de Respuesta Inflamatoria Sistémica/epidemiología , Resultado del Tratamiento
6.
World J Gastroenterol ; 14(44): 6876-80, 2008 Nov 28.
Artículo en Inglés | MEDLINE | ID: mdl-19058319

RESUMEN

A 68-year-old female visited a local clinic with epigastralgia. A routine laboratory test revealed jaundice and liver dysfunction. She was referred to this hospital. Abdominal computed tomography (CT) and endoscopic retrograde cholangio-pancreatography (ERCP) revealed that the density of the entire pancreas had decreased, and showed dilatation of the common bile duct (CBD) and the main pancreatic duct (MPD). Pancreatic cancer was diagnosed by cytological examination analyzing the pancreatic juice obtained by ERCP. When jaundice had decreased the tumor was observed via laparotomy. No ascites, liver metastasis, or peritoneal dissemination was observed. The entire pancreas was a hard mass, and a needle biopsy was obtained from the head, body and tail of the pancreas. These biopsies diagnosed a poorly differentiated adenocarcinoma. Hepaticojejunostomy was thus performed, and postoperative progress was good. Chemotherapy with 1000 mg/body per week of gemcitabine was administered beginning 15 d postoperatively. However, the patient suffered relatively severe side effects, and it was necessary to change the dosing schedule of gemcitabine. Abdominal CT revealed a complete response (CR) after 3 treatments. Therefore, weekly chemotherapy was stopped and was changed to monthly administration. To date, for 4 years after chemotherapy, the tumor has not reappeared.


Asunto(s)
Adenocarcinoma/tratamiento farmacológico , Antimetabolitos Antineoplásicos/administración & dosificación , Desoxicitidina/análogos & derivados , Neoplasias Pancreáticas/tratamiento farmacológico , Adenocarcinoma/patología , Adenocarcinoma/cirugía , Anciano , Antimetabolitos Antineoplásicos/efectos adversos , Diferenciación Celular , Quimioterapia Adyuvante , Colangiopancreatografia Retrógrada Endoscópica , Desoxicitidina/administración & dosificación , Desoxicitidina/efectos adversos , Procedimientos Quirúrgicos del Sistema Digestivo , Esquema de Medicación , Femenino , Humanos , Neoplasias Pancreáticas/patología , Neoplasias Pancreáticas/cirugía , Factores de Tiempo , Tomografía Computarizada por Rayos X , Resultado del Tratamiento , Gemcitabina
7.
Org Lett ; 18(14): 3490-3, 2016 07 15.
Artículo en Inglés | MEDLINE | ID: mdl-27355591

RESUMEN

A new monoterpenoid indole alkaloid, kopsiyunnanine K, was isolated from Kopsia arborea. Its intriguing rearranged structure and absolute configuration, which were inferred from spectral data and a possible biosynthetic pathway, were determined on the basis of a 13-step asymmetric total synthesis.

8.
Asian Cardiovasc Thorac Ann ; 14(4): e80-2, 2006 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-16868095

RESUMEN

A 7-year-old girl with tetralogy of Fallot in association with a single right coronary artery, was successfully re-operated on for right ventricular outflow tract obstruction. To identify the course of the abnormal coronary arteries during the re-operation, a probe was directly inserted into the coronary arteries after aortotomy. Ventriculotomy was successfully performed under the guide of the probe, without damaging the coronary arteries. Double outflow technique was applied for the relief of the right ventricular outflow tract obstruction.


Asunto(s)
Anomalías de los Vasos Coronarios/diagnóstico por imagen , Tetralogía de Fallot/cirugía , Niño , Angiografía Coronaria , Anomalías de los Vasos Coronarios/complicaciones , Femenino , Humanos , Reoperación , Tetralogía de Fallot/complicaciones
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda